Page last updated: 2024-08-22

galactosamine and tamoxifen

galactosamine has been researched along with tamoxifen in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, X; Jiang, Y; Luo, M; Wan, M; Xu, S; Zhang, M; Zhang, P1
Cao, P; Gong, X; Lin, Y; Liu, L; Luo, M; Wu, T; Yang, Q; Zhou, L1

Other Studies

2 other study(ies) available for galactosamine and tamoxifen

ArticleYear
Tamoxifen Attenuates Lipopolysaccharide/Galactosamine-induced Acute Liver Failure by Antagonizing Hepatic Inflammation and Apoptosis.
    Immunological investigations, 2017, Volume: 46, Issue:3

    Topics: Animals; Apoptosis; Caspase 3; Chemical and Drug Induced Liver Injury; Galactosamine; Humans; Interleukin-1beta; Lipopolysaccharides; Liver; Liver Failure, Acute; Mice; Mice, Inbred BALB C; Tamoxifen; Transaminases; Tumor Necrosis Factor-alpha

2017
Tamoxifen Prevents D-galactosamine/Lipopolysaccharide-Induced Murine Acute Hepatic Failure through Inhibition of Oxidative Stress and Mmd-2 Upregulation.
    Immunological investigations, 2018, Volume: 47, Issue:6

    Topics: Acetylcysteine; Alanine Transaminase; Animals; Antigens, Differentiation; Antioxidants; Aspartate Aminotransferases; Catalase; Galactosamine; Glutathione Peroxidase; Lipopolysaccharides; Liver Failure, Acute; Mice; Mice, Inbred BALB C; Oxidative Stress; Superoxide Dismutase; Tamoxifen; Up-Regulation

2018